Comparison of a once daily versus twice daily subcutaneous nadroparin calcium regimens in the treatment of deep vein thrombosis. On behalf of the Fraxodi group - Charbonnier, BA; Fiessinger, JN; Sixma, JJ; d’Azemar, P; Sagnard, L (Circulation, 1996)
(abst).